"Carnosine-Niosomal Delivery System for Targeted Cancer Therapy"

Area of Science:

• Nanomedicine
• Oncology
• Drug Delivery Systems

Background:

• Cancer remains a leading global cause of death, necessitating advanced therapeutic strategies.
• Nanomedicine offers novel approaches for disease treatment, utilizing pharmaceutical nanocarriers.
• Carnosine, a naturally occurring dipeptide, possesses antioxidant properties with potential anticancer applications.

Purpose of the Study:

• To investigate the efficacy of carnosine-loaded niosomes as a targeted cancer therapy.
• To evaluate the impact of niosome encapsulation on carnosine's stability and bioavailability.
• To compare the anticancer effects of carnosine-loaded niosomes with conventional treatments.

Main Methods:

• Fabrication of pharmaceutical nanocarriers (niosomes) using non-ionic surfactants and amphiphilic substances.
• Encapsulation of carnosine within the niosomes.
• Assessment of enhanced stability, bioavailability, and anticancer efficacy of carnosine-loaded niosomes in vitro and/or in vivo models.

Main Results:

• Encapsulation of carnosine in niosomes significantly enhanced its stability and bioavailability.
• Carnosine-loaded niosomes demonstrated a significant increase in anticancer efficacy.
• The nanocarrier system improved drug delivery specificity and reduced potential side effects.

Conclusions:

• Niosome technology serves as an effective delivery system for carnosine in cancer treatment.
• Carnosine-loaded niosomes represent a promising advancement in targeted cancer therapy.
• Further research into niosome-based drug delivery systems holds potential for transforming cancer treatment paradigms.